MRA Advisory Group Reduces Holdings in Bristol Myers Squibb Company $BMY
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
MRA Advisory Group significantly reduced its stake in Bristol Myers Squibb by 76.1% in the third quarter, selling 18,006 shares. Despite this, other major institutional investors like BlackRock and State Street increased their holdings, with institutional investors collectively owning 76.41% of the company. Bristol Myers Squibb reported strong quarterly earnings, exceeding estimates, and maintains a "Moderate Buy" consensus rating from analysts.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.